AR021636A1 - MATERIALS AND METHODS FOR THE MODIFICATION OF CONTENT, COMPOSITION AND METABOLISM OF ISOPRENOIDS - Google Patents

MATERIALS AND METHODS FOR THE MODIFICATION OF CONTENT, COMPOSITION AND METABOLISM OF ISOPRENOIDS

Info

Publication number
AR021636A1
AR021636A1 ARP990106323A AR021636A1 AR 021636 A1 AR021636 A1 AR 021636A1 AR P990106323 A ARP990106323 A AR P990106323A AR 021636 A1 AR021636 A1 AR 021636A1
Authority
AR
Argentina
Prior art keywords
metabolism
content
methods
isoprenoids
modification
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Rubicon Forests Holdings Ltd
Genesis Res & Dev Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rubicon Forests Holdings Ltd, Genesis Res & Dev Corp Ltd filed Critical Rubicon Forests Holdings Ltd
Publication of AR021636A1 publication Critical patent/AR021636A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8255—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving lignin biosynthesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)

Abstract

Se proveen los polinucleotidos nuevos aislados asociados con las vías biosintéticas de isoprenoide de plantas, junto con las construcciones genéticas quecomprenden a estas secuencias. También se describen los métodos para la modulacion del contenido,estructura y metabolismo de los polipéptidos involucrados enuna vía biosintética de isoprenoide en los organismos objetivo, los métodos que comprenden incorporar uno o más polinucleotidos o construcciones genéticas dela presente invencion dentro delgenoma de un organismo objetivo. La modulacion del contenido, estructura y metabolismo de estos polipéptidos producemodificaciones en el contenido, estructura y metabolismo de los isoprenoides en el organismo objetivo.New isolated polynucleotides associated with the biosynthetic pathways of plant isoprenoid are provided, together with the genetic constructs that comprise these sequences. The methods for modulating the content, structure and metabolism of the polypeptides involved in an isoprenoid biosynthetic pathway in the target organisms are also described, the methods comprising incorporating one or more polynucleotides or genetic constructs of the present invention within the genome of a target organism. Modulation of the content, structure and metabolism of these polypeptides produces changes in the content, structure and metabolism of isoprenoids in the target organism.

ARP990106323 1998-12-17 1999-12-13 MATERIALS AND METHODS FOR THE MODIFICATION OF CONTENT, COMPOSITION AND METABOLISM OF ISOPRENOIDS AR021636A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21550498A 1998-12-17 1998-12-17
US14644199P 1999-07-29 1999-07-29

Publications (1)

Publication Number Publication Date
AR021636A1 true AR021636A1 (en) 2002-07-31

Family

ID=26843909

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990106323 AR021636A1 (en) 1998-12-17 1999-12-13 MATERIALS AND METHODS FOR THE MODIFICATION OF CONTENT, COMPOSITION AND METABOLISM OF ISOPRENOIDS

Country Status (10)

Country Link
EP (1) EP1151081A2 (en)
JP (1) JP2002541764A (en)
CN (1) CN1334866A (en)
AR (1) AR021636A1 (en)
AU (1) AU1900100A (en)
BR (1) BR9917002A (en)
CA (1) CA2353910A1 (en)
ID (1) ID29580A (en)
MX (1) MXPA01006009A (en)
WO (1) WO2000036081A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9915021A (en) 1998-10-09 2001-08-14 Genesis Res & Dev Corp Ltd Materials and methods for modifying plant lignin content
EP1327686A4 (en) * 2000-10-06 2005-01-19 Sapporo Breweries Farnesyl pyrophosphate synthase protein, nucleic acid and promoter region thereof
DE10057755A1 (en) 2000-11-22 2002-05-23 Bayer Ag New nucleic acid encoding plant phosphomevalonate kinase, useful for identifying modulators, potentially useful as herbicides and growth regulators
US20030217384A1 (en) * 2002-02-05 2003-11-20 Harvell Leslie T. Obtusifoliol 14a-demethylase
US20040010818A1 (en) * 2002-05-09 2004-01-15 Mcgonigle Brian Transgenic plants with a suppressed triterpene level
US7402428B2 (en) 2004-09-22 2008-07-22 Arborgen, Llc Modification of plant lignin content
EP2347730A1 (en) * 2007-09-04 2011-07-27 Affinergy, Inc. Methods and compositions for delivery of growth factor to fibrous connective tissue
BR122021005304B1 (en) 2010-06-02 2022-02-22 Evolva, Inc Recombinant host comprising recombinant genes for producing steviol or steviol glycoside, nucleic acid, method for producing steviol, steviol glycoside or steviol glycoside composition, and method for synthesizing steviol or steviol glycoside
CN103732753B (en) 2011-08-08 2018-03-30 埃沃尔瓦公司 The recombinant production of steviol glycoside class
CA3171770A1 (en) 2013-02-06 2014-08-14 Evolva Sa Methods for improved production of rebaudioside d and rebaudioside m
EP2954061B1 (en) 2013-02-11 2023-11-22 Evolva SA Efficient production of steviol glycosides in recombinant hosts
MX2017001859A (en) 2014-08-11 2017-04-11 Evolva Sa Production of steviol glycosides in recombinant hosts.
SG11201701677UA (en) 2014-09-09 2017-04-27 Evolva Sa Production of steviol glycosides in recombinant hosts
CA2973674A1 (en) 2015-01-30 2016-08-04 Evolva Sa Production of steviol glycosides in recombinant hosts
US10604743B2 (en) 2015-03-16 2020-03-31 Dsm Ip Assets B.V. UDP-glycosyltransferases
WO2017025362A1 (en) 2015-08-07 2017-02-16 Evolva Sa Production of steviol glycosides in recombinant hosts
CA3020671A1 (en) 2016-04-13 2017-10-19 Evolva Sa Production of steviol glycosides in recombinant hosts
EP3458599A1 (en) 2016-05-16 2019-03-27 Evolva SA Production of steviol glycosides in recombinant hosts
EP3535406A1 (en) 2016-11-07 2019-09-11 Evolva SA Production of steviol glycosides in recombinant hosts

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265639B1 (en) * 1998-01-22 2001-07-24 Washington State University Foundation Gymnosperm nucleic acid molecules encoding sesquiterpene synthases and methods of use

Also Published As

Publication number Publication date
CN1334866A (en) 2002-02-06
JP2002541764A (en) 2002-12-10
WO2000036081A3 (en) 2000-08-03
WO2000036081A2 (en) 2000-06-22
ID29580A (en) 2001-09-06
EP1151081A2 (en) 2001-11-07
CA2353910A1 (en) 2000-06-22
AU1900100A (en) 2000-07-03
MXPA01006009A (en) 2002-04-15
BR9917002A (en) 2001-12-04

Similar Documents

Publication Publication Date Title
AR021636A1 (en) MATERIALS AND METHODS FOR THE MODIFICATION OF CONTENT, COMPOSITION AND METABOLISM OF ISOPRENOIDS
AR022895A1 (en) COMPOSITIONS AND METHODS FOR THE MODIFICATION OF THE GENICAL TRANSCRIPTION
ES2196593T3 (en) MODIFIED CARBON PRODUCTS WITH OUTGOING GROUPS FOR DYES AND COATINGS.
AR026994A1 (en) NEW EXPRESSION CONSTRUCTIONS IN PLANTS.
AR020884A1 (en) GENES OF VEGETABLE FATTY ACIDS MODIFICATOR ENZYMES ASSOCIATED WITH THE FORMATION OF DOUBLE LINKS
AR020021A1 (en) COMPOSITION FOR CANCER TREATMENT USING ESSENTIAL OILS OF NATURAL PLANTS WITH SENAL TRANSDUCTION MODULATORS
ES2148345T3 (en) PHARMACEUTICAL COMPOSITION WITH CYCLOSPORINE A, A DERIVATIVE OF VITAMIN E AND AN EMULSIONANT.
CY1116385T1 (en) ANTIMONATIC CONFIGURATION OF EXPRESSION OF APLIPOPROTEIN B
ES2166807T3 (en) PIRIDAZINONAS AND ITS USE AS FUNGICIDES.
BR9915191A (en) Methods to obtain an isolated polynucleotide and to produce a recombinant cell, plant cell protoplast, collection of plant cell, plant, polynucleotide, library, one or more library members and target recombinant cell
BR9915021A (en) Materials and methods for modifying plant lignin content
BR9814814A (en) Processes for modulating serine / threonine protein kinase function with 5-azaquinoxaline-based compounds
BR9909258A (en) Expression of trehalose biosynthetic genes in plants
SV2002000049A (en) USE OF CYP2D6 INHIBITORS IN COMBINATION WITH THERAPIES. REF. PC1044 ARFW / BB
ES2196502T3 (en) COMPOSITION AND METHOD TO INHIBIT THE DEVELOPMENT OF MICROORGANISMS THAT INCLUDES STABILIZED SODIUM HYPOOBROMYTE AND ISOTIAZOLONES.
ES2103373T3 (en) ELECTROPHORESIS DEVICE.
PT1117672E (en) Antisense modulation of survivin expression
AR036962A1 (en) AROMATIC METHYLTRANSPHERASES AND USES OF THE SAME
ES2152310T3 (en) DERIVATIVES OF 1-AMINO-3-PHENOXIPROPANE AS MODULATORS OF MULTIPLE RESISTANCE TO PHARMACOS.
ES2140078T3 (en) CYTOSTATICS MODIFIED WITH CARBON HYDRATES.
BR0209788A (en) Pigmented optical body
SV2003000887A (en) PPAR COMPOUNDS REF.PC11022AADO / BB
ES2179138T3 (en) POLYISOCIANATES THAT PRESENT ALOFANATO GROUPS BASED ON DIFENYLMETHANODIISOCIANATE WITH PREDOMINATING OR COMPLETELY BLOCKED ISOCIANATE GROUPS.
BR0313455A (en) "antisense" modulation of nav1.3 expression
BR0110087A (en) Compounds to modulate cell proliferation

Legal Events

Date Code Title Description
FA Abandonment or withdrawal